Patent: 9,486,522
✉ Email this page to a colleague
Summary for Patent: 9,486,522
Title: | Compositions including triciribine and trastuzumab and methods of use thereof |
Abstract: | This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation. |
Inventor(s): | Cheng; Jin Q. (Tampa, FL), Sebti; Said M. (Tampa, FL) |
Assignee: | University of South Florida (Tampa, FL) |
Application Number: | 14/881,777 |
Patent Claims: | see list of patent claims |
Details for Patent 9,486,522
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2024-03-29 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2024-03-29 |
Genentech, Inc. | HERCEPTIN HYLECTA | trastuzumab and hyaluronidase-oysk | Injection | 761106 | 02/28/2019 | ⤷ Try a Trial | 2024-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |